Vimarsana
Biggest News Aggregation in the World

Page 13 - Marrow Transplant Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marrow Transplant Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marrow Transplant Program Today - Breaking & Trending Today

NYU Langone opens new state-of-the-art center to treat patients with blood cancers - Vimarsana News

NYU Langone opens new state-of-the-art center to treat patients with blood cancers

NYU Langone Health's Laura and Isaac Perlmutter Cancer Center opened a new state-of-the-art center to treat people with blood cancers, including leukemia, lymphoma, and multiple myeloma.

Research project aims to make CAR-T-cell therapy safer and more effective - Vimarsana News

Research project aims to make CAR-T-cell therapy safer and more effective

A new project led by researchers at MUSC Hollings Cancer Center could significantly decrease the side effects associated with CAR-T-cell therapy and make...

Treatment program at Calgary's Tom Baker Cancer Centre offers 'new hope' for patients with certain blood cancers - Vimarsana News

Treatment program at Calgary's Tom Baker Cancer Centre offers 'new hope' for patients with certain blood cancers

  A new program using CAR T-cell therapy is underway at Calgary's Tom Baker Cancer Centre (TBCC) and is changing the way doctors approach the treatment of certain blood cancers. Chimeric antigen receptor T-cell (CAR T) therapy uses a person's own immune cells to fight cancer and will now be offered in Alberta to patients with specific kinds of leukemia and non-Hodgkin lymphoma. "CAR T-cell therapy has changed the way we approach the treatment of patients with relapsed/refractory non-Hodgkin lymphoma," said Dr. Mona Shafey, MD, FRCPC, hematologist and director of the Alberta Blood and Ma...

UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect - Vimarsana News

UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect

UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect April 1, 2021UCLA Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients’ own blood-forming stem cells. The trial will combine CRISPR technology developed at the Innovative Genomics Institute — a UC Berkeley–UCSF initiative founded by Berkeley’s Nobel Prize–winning scientist Jennifer Doud...

Trial begins to solve complicated treatment problem for child cancer - Vimarsana News

Trial begins to solve complicated treatment problem for child cancer

Trial begins to solve complicated treatment problem for child cancer We’re sorry, this service is currently unavailable. Please try again later. Dismiss Normal text size Advertisement A clinical trial is under way to prove the effectiveness of a new method developed by Queensland scientists to remove the major side-effect of a treatment for cancer and genetic disorders in children. The trial is expected to involve about 20 children aged between three months and 18 years who need stem cell treatment for blood cancers or genetic immune deficiencies. Researchers at QIMR Berghofer have develope...